TORRE, GIULIA
TORRE, GIULIA
Dipartimento di Biologia
A high degree of genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity.
2025-01-01 Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Magnapera, A; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Battista Gaeta, G; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V
A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity.
2024-01-01 Magnapera, A; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini., R
An increased genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity
2025-01-01 Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Magnapera, A; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Battista Gaeta, G; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V
Chronic HDV coinfection (CHD) is characterized by a different HBsAg isoforms composition respect to HBV mono-infection with higher middle- and large-HBs levels paralleling the replicative and cytolytic activity of HDV.
2024-01-01 Magnapera, 1a; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, G; Salpini, R; Svicher, V
Chronic HDV coinfection (CHD) is characterized by a more elevated production of Middle and Large HBsAg than HBV mono-infection, that parallels HDV replicative and cytolytic activity.
2024-01-01 Piermatteo, 1l; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini., R
Chronic HDV coinfection is characterized by a more elevated production of all three HBsAg isoforms compared to HBV mono-infection, that parallels HDV replicative and cytolytic activity.
2025-01-01 D’Anna, S; Piermatteo, L; Magnapera, A; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, L; Milella, M; Saracino, Al; Ciancio, Al; Silberstein, C; F, ; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini, R
Chronic HDV coinfection is characterized by a peculiar HBsAg isoforms composition respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity.
2024-01-01 Magnapera, A; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, G; Svicher, V; Salpini, R
Chronic HDV infection is sustained by an intense HBsAg production fromintegrated HBVDNA in the setting of a limited or even absent HBV reservoir.
2024-01-01 Salpini, 1r; D'Anna, S; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, A; Abate, Ml; Olivero, A; Gaeta, G; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher., V
Comparison of diagnostic performances of HDV-RNA quantification assays used in clinical practice: Results from a national quality control multicenter study
2025-10-01 Salpini, R; Piermatteo, L; Caviglia, Gp; Bertoli, A; Brunetto, Mr; Bruzzone, B; Callegaro, A; Caudai, C; Cavallone, D; Chessa, L; Coghe, F; Coppola, N; Cuomo, N; D'Anna, S; Di Stefano, M; Facchetti, F; Farina, C; Ferraro, D; Franchin, E; Francisci, D; Galli, S; Garbuglia, Ar; Gennari, W; Ghisetti, V; Lampertico, P; Lo Caputo, S; Marascio, N; Menzo, S; Micheli, V; Niro, Ga; Olivero, A; Paba, P; Palermo, Ci; Palmieri, O; Paolucci, S; Pisaturo, M; Pollicino, T; Raffa, G; Santantonio, T; Torre, G; Turriziani, O; Uzzau, S; Uceda Renteria, Sc; Vatteroni, M; Zazzi, M; Craxì, A; Ceccherini-Silberstein, F; Svicher, V; Arosio, M; Bastianelli, S; Gentile, A; Giardina, Fam; Gidari, A; Govoni, R; Ibba, G; Loglio, A; Lombardi, A; Mascarella, C; Maggi, F; Matera, G; Mazzei, C; Milia, Mg; Quirino, A; Raddi, A; Scioscia, R; Tagliazucchi, S; Totaro, M; Valaperta, R
Despite a substantial burden of HDV infection, gaps in HDV screening still persists across Europe: an urgent need to strengthen diagnostic strategies at pan-European level
2025-01-01 Salpini, R; Grossi, I; Alexiev, I; Baiocchi, L; Banica, L; Begovac, J; Benkoova, B; Bopegamage, S; Castelli, C; Caudai, C; D’Anna, S; Demir, T; Devaux, C; Di Lorenzo, A; Heger, E; Kaiser, R; Kokkinos, N; Fernandez-Rivas, G; Gazdikova, K; Geretti, Am; Golkocheva-Markova, E; Iserentant, G; Lazarevic, I; Lazureanu, V; Leuzinger, K; Lindh, M; Llibre, Jm; Lunar, Mm; Mihale, J; Mor, O; Nierhoff, D; Otelea, D; Piermatteo, L; Poljak, M; Riccio, Arm; Sarmati, L; Torre, G; Tudor, Am; Vata, A; Yildiran, D; Zazzi, M; Wensing, Amj; Svicher, V
Different diagnostic performances of HDV RNA quantification assays used in clinical practicein Italy: results from a national quality control multicenter study.
2024-01-01 Salpini, 7r; Piermatteo, L; Caviglia, Gp; Bertoli, A; Brunetto, Mr; Bruzzone, B; Callegaro, A; Caudai, C; Cavallone, D; Chessa, L; Coghe, F; Coppola, N; Cuomo, N; D'Anna, S; Di Stefano, M; Duca, L; Facchetti, F; Farina, C; Ferraro, D; Franchin, E; Francisci, D; Galli, S; Garbuglia, Ar; Gennari, W; Ghisetti, V; Lampertico, P; Marascio, N; Menzo, S; Micheli, V; Niro, G; Olivero, A; Paba, P; Palermo, Ci; Palmieri, O; Paolucci, S; Pisaturo, M; Pollicino, T; Raffa, G; Torre, G; Turriziani, O; Uzzau, S; Vatteroni, M; Zazzi, M; Craxì, A; Ceccherini-Silberstein, F; Svicher On Behalf Of The Virology Italian Network Vironet C., V
HBsAg Isoforms as Innovative Biomarkers in Predicting Virological Response to Bulevirtide in Patients With Chronic Hepatitis D
2025-05-01 D'Anna, S; Salpini, R; Degasperi, E; Piermatteo, L; Facchetti, F; Sambarino, D; Torre, G; Borghi, M; Anolli, Mp; Monico, S; Svicher, V; Lampertico, P
HBsAg production from integrated HBV-DNA sustains HDV persistence in the setting of a limited or even absent HBV reservoir
2024-01-01 D’Anna, 6s; Piermatteo, L; Teti, E; Di Lorenzo, A; Brancaccio, G; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini., R
HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV subgenotypes 1 inducing different inflammatory stimuli
2023-03-01 Salpini, R; Piermatteo, L; Torre, G; D’Anna, S; Khan, S; Duca, L; Bertoli, A; Malagnino, V; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Marignani, M; Pellicelli, A; Galati, G; Moretti, A; Colucci, G; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Grelli, S; Ceccherini Silberstein, F; Sarmati, L; V. Svicher.,
HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL
2023-01-01 R, S; Piermatteo, L; Torre, G; D’Anna, S; Khan, S; Duca, L; Bertoli, A; Malagnino, V; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Marignani, M; Pellicelli, A; Galati, G; Moretti, A; Colucci, G; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Grelli, S; Ceccherini-Silberstein, F; Sarmati, L; Svicher, V
HDV persistence acts independently from HBV reservoir extent and is sustained by HBsAg production mainly derived from integrated HBV-DNA
2025-01-01 D'Anna, S; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher, V; Salpini, R
HDV persistence is sustained by HBsAg mainly derived from integrated HBV-DNA and is independent from the extent of HBV reservoir
2024-01-01 D'Anna, 1s; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher, V; Salpini, R
HDV replicative activity parallels the production of the three HBsAg forms (Large, Middle and Small HBsAg) and its pathogenetic impact is exacerbated by concomitant HBV replication
2023-01-01 Duca, L; Olivero, A; Piermatteo, L; D’Anna, S; Torre, G; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini, R
HDV sub-genotype 1 is characterized by increased genetic variability, which can promote the emergence of divergent genetic pathways that modulate HDV replicative potential and cytolytic activity.
2025-01-01 Magnapera, A; Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Gaeta, Gb; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V
HDV sub-genotype 1 is characterized by increased genetic variability, which can promote the emergence of divergent genetic pathways that modulate HDV replicative potential and cytolytic activity.
2025-01-01 Magnapera, A; Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Gaeta, Gb; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Salpini, R; Svicher, V
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2025 | A high degree of genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity. | Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Magnapera, A; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Battista Gaeta, G; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V | Intervento a convegno | |
| 1-gen-2024 | A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. | Magnapera, A; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini., R | Intervento a convegno | |
| 1-gen-2025 | An increased genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity | Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Magnapera, A; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Battista Gaeta, G; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V | Intervento a convegno | |
| 1-gen-2024 | Chronic HDV coinfection (CHD) is characterized by a different HBsAg isoforms composition respect to HBV mono-infection with higher middle- and large-HBs levels paralleling the replicative and cytolytic activity of HDV. | Magnapera, 1a; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, G; Salpini, R; Svicher, V | Intervento a convegno | |
| 1-gen-2024 | Chronic HDV coinfection (CHD) is characterized by a more elevated production of Middle and Large HBsAg than HBV mono-infection, that parallels HDV replicative and cytolytic activity. | Piermatteo, 1l; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini., R | Intervento a convegno | |
| 1-gen-2025 | Chronic HDV coinfection is characterized by a more elevated production of all three HBsAg isoforms compared to HBV mono-infection, that parallels HDV replicative and cytolytic activity. | D’Anna, S; Piermatteo, L; Magnapera, A; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, L; Milella, M; Saracino, Al; Ciancio, Al; Silberstein, C; F, ; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2024 | Chronic HDV coinfection is characterized by a peculiar HBsAg isoforms composition respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. | Magnapera, A; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, G; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2024 | Chronic HDV infection is sustained by an intense HBsAg production fromintegrated HBVDNA in the setting of a limited or even absent HBV reservoir. | Salpini, 1r; D'Anna, S; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, A; Abate, Ml; Olivero, A; Gaeta, G; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher., V | Intervento a convegno | |
| 1-ott-2025 | Comparison of diagnostic performances of HDV-RNA quantification assays used in clinical practice: Results from a national quality control multicenter study | Salpini, R; Piermatteo, L; Caviglia, Gp; Bertoli, A; Brunetto, Mr; Bruzzone, B; Callegaro, A; Caudai, C; Cavallone, D; Chessa, L; Coghe, F; Coppola, N; Cuomo, N; D'Anna, S; Di Stefano, M; Facchetti, F; Farina, C; Ferraro, D; Franchin, E; Francisci, D; Galli, S; Garbuglia, Ar; Gennari, W; Ghisetti, V; Lampertico, P; Lo Caputo, S; Marascio, N; Menzo, S; Micheli, V; Niro, Ga; Olivero, A; Paba, P; Palermo, Ci; Palmieri, O; Paolucci, S; Pisaturo, M; Pollicino, T; Raffa, G; Santantonio, T; Torre, G; Turriziani, O; Uzzau, S; Uceda Renteria, Sc; Vatteroni, M; Zazzi, M; Craxì, A; Ceccherini-Silberstein, F; Svicher, V; Arosio, M; Bastianelli, S; Gentile, A; Giardina, Fam; Gidari, A; Govoni, R; Ibba, G; Loglio, A; Lombardi, A; Mascarella, C; Maggi, F; Matera, G; Mazzei, C; Milia, Mg; Quirino, A; Raddi, A; Scioscia, R; Tagliazucchi, S; Totaro, M; Valaperta, R | Articolo su rivista | |
| 1-gen-2025 | Despite a substantial burden of HDV infection, gaps in HDV screening still persists across Europe: an urgent need to strengthen diagnostic strategies at pan-European level | Salpini, R; Grossi, I; Alexiev, I; Baiocchi, L; Banica, L; Begovac, J; Benkoova, B; Bopegamage, S; Castelli, C; Caudai, C; D’Anna, S; Demir, T; Devaux, C; Di Lorenzo, A; Heger, E; Kaiser, R; Kokkinos, N; Fernandez-Rivas, G; Gazdikova, K; Geretti, Am; Golkocheva-Markova, E; Iserentant, G; Lazarevic, I; Lazureanu, V; Leuzinger, K; Lindh, M; Llibre, Jm; Lunar, Mm; Mihale, J; Mor, O; Nierhoff, D; Otelea, D; Piermatteo, L; Poljak, M; Riccio, Arm; Sarmati, L; Torre, G; Tudor, Am; Vata, A; Yildiran, D; Zazzi, M; Wensing, Amj; Svicher, V | Intervento a convegno | |
| 1-gen-2024 | Different diagnostic performances of HDV RNA quantification assays used in clinical practicein Italy: results from a national quality control multicenter study. | Salpini, 7r; Piermatteo, L; Caviglia, Gp; Bertoli, A; Brunetto, Mr; Bruzzone, B; Callegaro, A; Caudai, C; Cavallone, D; Chessa, L; Coghe, F; Coppola, N; Cuomo, N; D'Anna, S; Di Stefano, M; Duca, L; Facchetti, F; Farina, C; Ferraro, D; Franchin, E; Francisci, D; Galli, S; Garbuglia, Ar; Gennari, W; Ghisetti, V; Lampertico, P; Marascio, N; Menzo, S; Micheli, V; Niro, G; Olivero, A; Paba, P; Palermo, Ci; Palmieri, O; Paolucci, S; Pisaturo, M; Pollicino, T; Raffa, G; Torre, G; Turriziani, O; Uzzau, S; Vatteroni, M; Zazzi, M; Craxì, A; Ceccherini-Silberstein, F; Svicher On Behalf Of The Virology Italian Network Vironet C., V | Intervento a convegno | |
| 1-mag-2025 | HBsAg Isoforms as Innovative Biomarkers in Predicting Virological Response to Bulevirtide in Patients With Chronic Hepatitis D | D'Anna, S; Salpini, R; Degasperi, E; Piermatteo, L; Facchetti, F; Sambarino, D; Torre, G; Borghi, M; Anolli, Mp; Monico, S; Svicher, V; Lampertico, P | Articolo su rivista | |
| 1-gen-2024 | HBsAg production from integrated HBV-DNA sustains HDV persistence in the setting of a limited or even absent HBV reservoir | D’Anna, 6s; Piermatteo, L; Teti, E; Di Lorenzo, A; Brancaccio, G; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini., R | Intervento a convegno | |
| 1-mar-2023 | HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV subgenotypes 1 inducing different inflammatory stimuli | Salpini, R; Piermatteo, L; Torre, G; D’Anna, S; Khan, S; Duca, L; Bertoli, A; Malagnino, V; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Marignani, M; Pellicelli, A; Galati, G; Moretti, A; Colucci, G; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Grelli, S; Ceccherini Silberstein, F; Sarmati, L; V. Svicher., | Intervento a convegno | |
| 1-gen-2023 | HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL | R, S; Piermatteo, L; Torre, G; D’Anna, S; Khan, S; Duca, L; Bertoli, A; Malagnino, V; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Marignani, M; Pellicelli, A; Galati, G; Moretti, A; Colucci, G; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Grelli, S; Ceccherini-Silberstein, F; Sarmati, L; Svicher, V | Intervento a convegno | |
| 1-gen-2025 | HDV persistence acts independently from HBV reservoir extent and is sustained by HBsAg production mainly derived from integrated HBV-DNA | D'Anna, S; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2024 | HDV persistence is sustained by HBsAg mainly derived from integrated HBV-DNA and is independent from the extent of HBV reservoir | D'Anna, 1s; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2023 | HDV replicative activity parallels the production of the three HBsAg forms (Large, Middle and Small HBsAg) and its pathogenetic impact is exacerbated by concomitant HBV replication | Duca, L; Olivero, A; Piermatteo, L; D’Anna, S; Torre, G; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2025 | HDV sub-genotype 1 is characterized by increased genetic variability, which can promote the emergence of divergent genetic pathways that modulate HDV replicative potential and cytolytic activity. | Magnapera, A; Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Gaeta, Gb; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V | Intervento a convegno | |
| 1-gen-2025 | HDV sub-genotype 1 is characterized by increased genetic variability, which can promote the emergence of divergent genetic pathways that modulate HDV replicative potential and cytolytic activity. | Magnapera, A; Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Gaeta, Gb; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Salpini, R; Svicher, V | Intervento a convegno |